vexibinol has been researched along with Congenital Zika Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hadj, SB; Han, X; Lin, R; Olagnier, D; Shi, Q; Sze, A; Tian, XH; Wainberg, MA; Wang, P; Wu, JH; Xu, HT; Yang, L | 1 |
1 other study(ies) available for vexibinol and Congenital Zika Syndrome
Article | Year |
---|---|
Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
Topics: Antiviral Agents; Cell Line; Dengue; Dengue Virus; Drug Discovery; Flavanones; Flaviviridae; Hepacivirus; Humans; Plant Roots; RNA-Dependent RNA Polymerase; Sophora; Virus Replication; Zika Virus; Zika Virus Infection | 2017 |